Date published: 2025-10-21

1-800-457-3801

SCBT Portrait Logo
Seach Input

Physostigmine salicylate (CAS 57-64-7)

0.0(0)
Write a reviewAsk a question

See product citations (1)

Alternate Names:
Eserine salicylate salt
Application:
Physostigmine salicylate is an analogue of Physostigmine
CAS Number:
57-64-7
Molecular Weight:
413.47
Molecular Formula:
C15H21N3O2•C7H6O3
Supplemental Information:
This is classified as a Dangerous Good for transport and may be subject to additional shipping charges.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Physostigmine salicylate is a derivative of Physostigmine (sc-202764). Physostigmine is an alkaloid originally derived from the Calabar bean (Physostigma venenosum) and noted to act as a potent and reversible inhibitor of cholinesterase. Physostigmine is also reported to form a slowly degrading carbamylated enzyme complex with acetylcholinesterase (AChE). This compound has been used as a positive control in a study investigating acetylcholinesterase inhibitors for potential antihelminthic drug targets. Additionally, this parasympathomimetic compound is reported to cross the blood-brain barrier.


Physostigmine salicylate (CAS 57-64-7) References

  1. In vitro release and intestinal absorption of physostigmine salicylate from submicron emulsions.  |  Rubinstein, A., et al. 1991. J Pharm Sci. 80: 643-7. PMID: 1941560
  2. Effects of subcutaneous and intracerebroventricular injection of physostigmine on the acute corneal nociception in rats.  |  Tamaddonfard, E. and Hamzeh-Gooshchi, N. 2010. Pharmacol Rep. 62: 858-63. PMID: 21098868
  3. Cholinergic modulation of narcoleptic attacks in double orexin receptor knockout mice.  |  Kalogiannis, M., et al. 2011. PLoS One. 6: e18697. PMID: 21533254
  4. Anticholinesterasic, nematostatic and anthelmintic activities of pyridinic and pyrazinic compounds.  |  Valli, M., et al. 2011. Curr Med Chem. 18: 3423-30. PMID: 21728957
  5. Toxicity study of continuous administration of physostigmine salicylate.  |  Lim, DK., et al. 1988. Pharmacol Biochem Behav. 31: 627-31. PMID: 3251246
  6. An acetylcholine-dopamine interaction in the nucleus accumbens and its involvement in ethanol's dopamine-releasing effect.  |  Loftén, A., et al. 2021. Addict Biol. 26: e12959. PMID: 32789970
  7. The effects of autoclaving on the stability of physostigmine salicylate in buffer solutions.  |  Yang, ST. and Wilken, LO. 1988. J Parenter Sci Technol. 42: 62-7. PMID: 3385544
  8. Multiple cholinesterase inhibitors have antidepressant-like properties in the mouse forced swim test.  |  Fitzgerald, PJ., et al. 2021. Behav Brain Res. 409: 113323. PMID: 33910028
  9. Rosinidin Protects Streptozotocin-Induced Memory Impairment-Activated Neurotoxicity by Suppressing Oxidative Stress and Inflammatory Mediators in Rats.  |  Alharbi, KS., et al. 2022. Medicina (Kaunas). 58: PMID: 35893108
  10. Neuroprotective Efficacy of Europinidin in Streptozotocin-Induced Memory Impairment by Modulation of Oxidative Stress, Inflammatory Mediators, and Cholinesterase Activity in Rats.  |  Ahmad, A. 2023. Oxid Med Cell Longev. 2023: 5248127. PMID: 36760351
  11. Structural Insights into the Marine Alkaloid Discorhabdin G as a Scaffold towards New Acetylcholinesterase Inhibitors.  |  Defant, A., et al. 2024. Mar Drugs. 22: PMID: 38667790
  12. Liquid chromatographic analysis of physostigmine salicylate and its degradation products.  |  Rubnov, S., et al. 1999. J Pharm Biomed Anal. 18: 939-45. PMID: 9925328

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Physostigmine salicylate, 25 mg

sc-252784
25 mg
$618.00